Breaking News

An overdose sensor for public bathrooms, help for heart patients' mental health, & remembering Sid Wolfe

January 3, 2024
Reporter, Morning Rounds Writer
Happy New Year, all. Hoping you're feeling well rested and ready to take on the world, if you were lucky — as our team was — to take a break. We've highlighted some recent STAT stories you may have missed in the last item of our newsletter.

addiction

Overdose sensors bring early-warning systems to public bathrooms 

Once in a while, electrician John King will get a call from a client saying, "John, we saved someone today." King was hired by Boston Health Care for the Homeless Program, a clinic that caters to Boston's unhoused population in the city's infamous "methadone mile," to stop near-daily bathroom overdoses. So he devised a specialized motion-sensor system to detect overdoses. When it works, "it's like going back in time — like I invented a time machine," King said.

Bathrooms in libraries, coffee shops, health clinics, and schools have become venues for drug use, creating a need for "safe bathroom" technology that notifies health workers of overdoses as they happen so they can administer naloxone and start rescue breathing. Despite its success in Boston, some addiction experts see the program as a symbol of the country's broader failure to prevent drug deaths. Read STAT's story from Lev Facher and watch the video from Alex Hogan and Anna Yeo.


in the lab

The Allen Institute's Rui Costa on changing science

rui costaCourtesy Allen Institute

Allen Institute researchers recently played a leading role in mapping the complete mouse brain, a first for any mammal and a prime example of the nonprofit's mission to go after big and basic scientific questions. CEO Rui Costa talked with STAT's Jonathan Wosen about the institute's approach to science and scientists.

On the possible benefits of mapping the human brain:

Right now, in neurodegeneration and dementia and especially in mental health, if you have a problem in the brain and you go to the hospital, you are treated very differently than if you have cancer. If you have cancer, they'll tell you what type of cancer it is. They'll tell you which cell types are involved. They will try to target that specifically. We're not there where we can say with precision which brain circuits are affected and why. And I think we can get there.

On why the institute pays $100,000 to scientists fresh out of graduate school, far more than most postdocs receive: 

It's not that money drives people; money drives people out. People cannot afford to stay in science. If you come from a disadvantaged background or ethnicity, this drives you out. If you want to be serious about changing how the next generation of STEM looks, you have to put your money where your mouth is.

Read the full interview.


remembrance

How iconoclast Sid Wolfe held regulators to account — and tutored journalists

The first time Public Citizen's Sid Wolfe called Ed Silverman more than 25 years ago, he embarked on a monologue filled with outrage and frustration — a fitting introduction to a man who'll be remembered as a true pharmaceutical industry watchdog. Wolfe, who died of brain cancer Monday at age 86, was trained as a medical doctor, but chose advocacy to make a bigger impact on patients. He put his training to good use by sifting through medical journals and working with Public Citizen staffers to identify laws and regulations to push the FDA and other government agencies to bolster their oversight of manufacturers.

"Not to dramatize the case, but he served as something of a conscience for regulators and industry, whether they liked it or not. And not surprisingly, his badgering was not always appreciated," Ed writes. "I'll miss those calls and the ensuing insights." Read more about Wolfe's impact.



above) closer look

Cardiac psychologists work to protect people's hearts and minds, tooCardiacSupportGroup_Falcigno-10-1600x900

Olivia Falcigno for STAT 

Margery Quackenbush was attending a work meeting when she felt a sharp, stabbing pain in her chest, the result of an artery blockage that required a stent. "The whole thing came as a shock. I like to tell people I didn't know I had a heart," she told STAT contributor Gina Ryder. Fifteen years later, she is far more aware of her heart, thanks in part to the psychological and behavioral support she's received while navigating heart disease — a need often neglected in the U.S. health care.

Study after study has shown that depression is both a risk factor for developing cardiac disease and a risk factor after heart surgery. "For whatever reason, there's been a general lack of acceptance when people say, 'Oh, yeah, we think it's important,' but it has never actually made its way into the care of patients with heart disease," said Duke's James Blumenthal. Read more.


transplant medicine

Case study offers hope for partial heart transplants in newborns

Babies born with irreparable heart valve problems who receive non-living replacement valves face a series of operations because those grafts cannot grow with them. These implants are tied to a 50% death rate in infancy, higher than the 15% rate from a full heart transplant in infancy, but that rate rises when neonatal transplants are followed by ventricular dysfunction by age 20. Now a case study in JAMA describes the partial heart transplant of just the heart valves.

Since the procedure was performed in April 2022, when the baby was 18 days old, the part of the heart containing aortic and pulmonary valves has grown along with the now 1-year-old patient, who needs about a quarter of the amount of immunosuppressant medication a full heart transplant would require. More patients and longer follow-up are needed, but the authors are hopeful that partial heart transplant might improve the treatment.


don't miss

The quest to end obesity, an algorithm to deny rehab care, and taxpayer funds diverted from health care

Here's what you might have missed since the last newsletter of 2023:

  • New weight-loss drugs might have been the top story of 2023 in our world. But what's next? STAT's Elaine Chen, Andrew Joseph, and Damian Garde tell us that the same drug companies that sparked an obesity treatment revolution are already on a mission to eliminate obesity altogether. Read their special report.
  • STAT's Bob Herman and Casey Ross have been tracking how UnitedHealth Group has used an algorithm to cut off rehab care for Medicare Advantage patients. Now they reveal that the health insurance giant used secret rules to deny care before patients even got to rehab. Read their latest investigation.
  • Rachel Cohrs tells a story of broken promises. Taxpayers in Travis County have been supporting a new medical school as part of a deal to bring more health care services to poor people in a state with the country's worst uninsured rate. Instead, the University of Texas at Austin is charging Travis County taxpayers millions more every year to cover care for the low-income patients the plan was supposed to help in the first place. Read her special report.

More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • Treatment for acute sleeping sickness has been brutal — until now, NPR

  • Adam's Take: A single drug and multiple study failures leave Anavex with nothing but cash, STAT
  • What ever happened to Zika? The Atlantic
  • LabCentral, a crucial incubator for local drug discovery, is slated to grow amid industry slowdown, Boston Globe

Thanks for reading! More tomorrow,


Enjoying Morning Rounds? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments